# Legal Framework & Ethics Policy

## 🔒 Malware Analysis Lab - Legal & Ethical Compliance

**Last Updated:** November 2025
**Compliance Officer:** Security Research Team
**Review Cycle:** Quarterly

---

## 1. PURPOSE & SCOPE

This document establishes the legal and ethical framework for operating the MASARE (Malware Analysis Sandbox with Automated Reverse Engineering) laboratory. All personnel accessing, analyzing, or handling malware samples must adhere to these policies.

### 1.1 Objectives

- Ensure compliance with applicable laws and regulations
- Protect organizational assets and personnel
- Maintain ethical standards in security research
- Prevent misuse of malware samples and analysis tools
- Establish clear accountability and chain-of-custody procedures

### 1.2 Scope

This framework applies to:
- All malware samples stored, analyzed, or processed in the lab
- All personnel with access to lab infrastructure
- All analysis tools, scripts, and automation systems
- All reports, IOCs, and threat intelligence generated
- All data sharing and disclosure activities

---

## 2. LEGAL COMPLIANCE

### 2.1 Applicable Laws & Regulations

#### 2.1.1 Computer Fraud & Abuse (CFAA)
**United States - 18 U.S.C. § 1030**

✅ **Compliance Measures:**
- Malware samples are **NEVER** executed on production systems
- All analysis occurs in isolated, air-gapped virtual environments
- No unauthorized access to external computer systems
- No distribution of malware to unauthorized parties

#### 2.1.2 Australian Cybercrime Act 2001
**Criminal Code Act 1995 (Cth) - Part 10.7**

✅ **Compliance Measures:**
- Research conducted for **lawful security purposes** (Section 478.1 exemption)
- No creation or distribution of malicious code for unauthorized purposes
- Proper authorization documented for all malware samples
- Compliance with data protection and privacy requirements

#### 2.1.3 GDPR & Data Protection
**General Data Protection Regulation (EU) 2016/679**

✅ **Compliance Measures:**
- No processing of personal data extracted from malware samples
- Anonymization of any PII discovered during analysis
- Secure deletion protocols for sensitive information
- Data retention policies aligned with research objectives

#### 2.1.4 Export Control Regulations
**EAR/ITAR - U.S. Export Administration Regulations**

✅ **Compliance Measures:**
- No sharing of advanced malware analysis tools with restricted entities
- Verification of recipients before sharing threat intelligence
- Compliance with dual-use technology export restrictions

### 2.2 Legal Authorization

All malware analysis activities are conducted under the following legal basis:

1. **Security Research Exception**: Research conducted for defensive security purposes
2. **Public Domain Samples**: All samples sourced from approved public repositories
3. **Isolated Environment**: Analysis confined to controlled lab infrastructure
4. **No Weaponization**: Tools and findings used exclusively for defensive purposes

---

## 3. APPROVED MALWARE SOURCES

### 3.1 Authorized Repositories

Only malware samples from the following **verified, public repositories** are permitted:

| Repository | URL | Authorization | Access Method |
|------------|-----|---------------|---------------|
| **VirusShare** | https://virusshare.com | Password-protected public archive | Registered account |
| **MalwareBazaar** | https://bazaar.abuse.ch | abuse.ch public intelligence | API access |
| **Any.run** | https://any.run | Public interactive sandbox | Web interface |
| **Hybrid-Analysis** | https://hybrid-analysis.com | VirusTotal integration | API key |
| **VirusTotal** | https://virustotal.com | Public malware repository | API access |
| **URLhaus** | https://urlhaus.abuse.ch | Malicious URL database | API access |
| **MalShare** | https://malshare.com | Community malware repository | API key |

### 3.2 Sample Acquisition Policy

**CRITICAL REQUIREMENTS:**

✅ Each malware sample must be:
1. From an approved public repository (listed above)
2. Already-known malware with public disclosure or CVE
3. Documented with proper source attribution
4. Encrypted immediately upon download (AES-256)
5. Stored in isolated, access-controlled directory
6. Logged with SHA-256 hash, acquisition date, and source

❌ **PROHIBITED:**
- Acquiring samples from untrusted sources
- Downloading samples via peer-to-peer networks
- Extracting samples from live production systems without authorization
- Reverse-engineering proprietary software without permission
- Creating new malware variants for testing purposes

### 3.3 Chain-of-Custody Documentation

For each malware sample, maintain the following records:

```json
{
  "sample_id": "unique_identifier",
  "sha256": "hash_value",
  "md5": "hash_value",
  "acquisition_date": "2025-11-15T10:00:00Z",
  "source_repository": "MalwareBazaar",
  "source_url": "https://bazaar.abuse.ch/sample/abc123",
  "malware_family": "Emotet",
  "threat_level": "CRITICAL",
  "authorization": "Public domain malware sample",
  "encryption_method": "AES-256-CBC",
  "storage_location": "/encrypted/malware/samples/emotet_variant_2025.bin.enc",
  "accessed_by": ["analyst_username"],
  "access_log": [
    {"timestamp": "2025-11-15T10:30:00Z", "action": "analysis", "user": "analyst1"}
  ]
}
```

---

## 4. SECURITY & ISOLATION REQUIREMENTS

### 4.1 Network Isolation

**MANDATORY CONTROLS:**

✅ All malware analysis VMs must be:
1. **Air-gapped** from production networks
2. Configured with **Host-Only networking** (no internet access)
3. Routed through **pfSense firewall** with egress blocking
4. Monitored with **intrusion detection** (Snort/Suricata)
5. Verified with isolation tests before use

**Network Architecture:**
```
┌─────────────────────────────────────────┐
│         PRODUCTION NETWORK              │
│              (BLOCKED)                  │
└─────────────────────────────────────────┘
                  ⛔ NO ACCESS
                     ▼
┌─────────────────────────────────────────┐
│       MALWARE ANALYSIS LAB              │
│      (192.168.1.0/24 - Isolated)        │
│                                         │
│  ┌──────────┐  ┌──────────┐  ┌──────┐  │
│  │ REMnux   │  │ FLARE VM │  │pfSense│  │
│  │ Analysis │  │ Windows  │  │Router │  │
│  │   VM     │  │ Sandbox  │  │       │  │
│  └──────────┘  └──────────┘  └──────┘  │
│                                         │
│  All traffic BLOCKED except:            │
│  - Internal VM communication            │
│  - Monitoring/logging to host           │
└─────────────────────────────────────────┘
```

### 4.2 Malware Storage Encryption

**ENCRYPTION PROTOCOL:**

```bash
# Encrypt malware sample with AES-256
gpg --symmetric --cipher-algo AES256 malware_sample.bin

# Store passphrase in secure vault (NOT in code)
# Use hardware security module (HSM) or password manager

# Decrypt for analysis (in isolated VM only)
gpg --decrypt malware_sample.bin.gpg > /tmp/sample.bin

# Secure deletion after analysis
shred -u -z -n 3 /tmp/sample.bin
```

**Key Management:**
- Passphrases stored in **KeePassXC** or **1Password** vault
- Access restricted to authorized analysts
- Encryption keys rotated every 90 days
- Backup keys stored in secure offline location

### 4.3 VM Snapshot Management

**SNAPSHOT POLICY:**

1. **Baseline Snapshot**: Clean VM state before any analysis
2. **Pre-Analysis Snapshot**: Immediately before malware execution
3. **Post-Analysis Snapshot**: After analysis for forensic review
4. **Rollback Procedure**: Restore to baseline after each sample

```bash
# VirtualBox snapshot management
VBoxManage snapshot "REMnux" take "baseline_clean" --description "Clean state 2025-11-15"
VBoxManage snapshot "REMnux" restore "baseline_clean"

# UTM snapshot management (M-series Mac)
# Use GUI: Right-click VM → Snapshots → Create/Restore
```

---

## 5. ETHICAL STANDARDS

### 5.1 Responsible Disclosure

**POLICY:**

When discovering new vulnerabilities, zero-days, or previously unknown malware:

1. **DO NOT** publicly disclose immediately
2. **DO** follow coordinated disclosure timeline:
   - Day 0: Internal review and validation
   - Day 1-7: Notify affected vendors/CERT
   - Day 30-90: Allow vendor time to patch
   - Day 90+: Public disclosure (if vendor unresponsive)

3. **Report to:**
   - Vendor security team (security@vendor.com)
   - CERT/CC (cert@cert.org)
   - National CERT (e.g., ACSC for Australia)

### 5.2 Prohibited Activities

❌ **NEVER:**
1. Execute malware on connected systems
2. Use analysis tools for unauthorized penetration testing
3. Share live malware samples with unauthorized parties
4. Weaponize malware for offensive purposes
5. Analyze samples for criminal intent
6. Bypass security controls on production systems
7. Reverse-engineer licensed software without permission
8. Create malware for testing without proper authorization

### 5.3 Professional Conduct

✅ **ALWAYS:**
1. Follow principle of least privilege (minimal access required)
2. Document all analysis activities with timestamps
3. Report security incidents immediately
4. Maintain confidentiality of sensitive findings
5. Respect intellectual property rights
6. Adhere to professional codes of conduct (e.g., ISC² Code of Ethics)

---

## 6. DATA HANDLING & RETENTION

### 6.1 Data Classification

| Data Type | Classification | Retention Period | Encryption Required |
|-----------|---------------|------------------|---------------------|
| Malware Samples | CONFIDENTIAL | 2 years | AES-256 |
| Analysis Reports | INTERNAL | 5 years | TLS in transit |
| IOC Feeds | PUBLIC | Indefinite | No |
| YARA Rules | PUBLIC | Indefinite | No |
| VM Snapshots | CONFIDENTIAL | 90 days | Full disk encryption |
| Access Logs | INTERNAL | 7 years | No |

### 6.2 Secure Deletion

**DATA DISPOSAL PROTOCOL:**

```bash
# Secure file deletion (3-pass overwrite)
shred -u -z -n 3 sensitive_file.bin

# Secure directory deletion
find /path/to/directory -type f -exec shred -u -z -n 3 {} \;

# VM secure deletion
VBoxManage unregistervm "OldAnalysisVM" --delete
# Then overwrite VMDK files:
shred -u -z -n 3 *.vmdk
```

### 6.3 Backup & Recovery

**BACKUP POLICY:**
- Analysis reports: Encrypted backup to secure cloud storage (AWS S3 with SSE)
- YARA rules: Version-controlled in GitHub (public repository)
- Malware samples: **NOT** backed up to cloud (local encrypted storage only)
- VM images: Encrypted backups to external USB drive (air-gapped)

---

## 7. INCIDENT RESPONSE

### 7.1 Security Incident Reporting

**ESCALATION PROCEDURE:**

If malware escapes isolation or unauthorized access occurs:

1. **IMMEDIATE (0-15 minutes):**
   - Shut down all lab VMs
   - Disconnect host machine from network
   - Notify security team lead

2. **SHORT-TERM (15-60 minutes):**
   - Document incident timeline
   - Assess impact and containment
   - Preserve forensic evidence

3. **LONG-TERM (1-24 hours):**
   - Root cause analysis
   - Implement corrective actions
   - Update security controls
   - Incident report to management

### 7.2 Contact Information

**EMERGENCY CONTACTS:**

- **Security Team Lead:** security@example.com
- **CERT Australia (ACSC):** https://www.cyber.gov.au/report
- **US-CERT:** https://us-cert.cisa.gov/report
- **Local Law Enforcement:** (Emergency: 000 AU / 911 US)

---

## 8. TRAINING & AUTHORIZATION

### 8.1 Required Training

All personnel accessing the malware analysis lab must complete:

1. **Security Awareness Training** (Annual)
2. **Malware Handling Procedures** (Quarterly)
3. **Ethical Hacking & Responsible Disclosure** (Annual)
4. **Data Protection & Privacy** (Annual)

### 8.2 Access Authorization

**ACCESS LEVELS:**

| Role | Permissions | Authorization Required |
|------|-------------|------------------------|
| **Security Analyst** | Read/analyze samples, generate reports | Manager approval |
| **Senior Researcher** | Full lab access, modify infrastructure | Director approval |
| **Auditor** | Read-only access to logs and reports | Compliance team |
| **External Collaborator** | Limited sample access (case-by-case) | NDA + Director approval |

---

## 9. COMPLIANCE MONITORING

### 9.1 Audit Schedule

- **Weekly:** Access log review
- **Monthly:** Network isolation verification tests
- **Quarterly:** Legal compliance review
- **Annually:** Full security audit by external party

### 9.2 Compliance Checklist

```
☐ All malware samples from approved repositories
☐ Encryption enabled for all stored samples
☐ Network isolation verified (no internet access)
☐ VM snapshots current and tested
☐ Access logs complete and accurate
☐ Incident response plan tested
☐ Personnel training up-to-date
☐ Data retention policies enforced
☐ Responsible disclosure process followed
☐ Legal authorization documented
```

---

## 10. ACKNOWLEDGMENTS & REFERENCES

This legal framework is based on industry best practices and guidance from:

- **NIST Cybersecurity Framework** (CSF)
- **SANS Institute** - Malware Analysis Guidelines
- **CERT/CC** - Coordinated Vulnerability Disclosure
- **OWASP** - Secure Coding & Testing Practices
- **ISC² Code of Ethics** - Professional Standards

---

## 11. DOCUMENT CONTROL

**Version History:**

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-11-15 | Security Research Team | Initial release |

**Approval:**

- **Security Director:** ______________________ Date: __________
- **Legal Counsel:** ______________________ Date: __________
- **Compliance Officer:** ______________________ Date: __________

---

## 12. ATTESTATION

By accessing the MASARE malware analysis laboratory, I acknowledge that:

1. I have read and understood this Legal Framework & Ethics Policy
2. I will comply with all legal, ethical, and security requirements
3. I will immediately report any security incidents or policy violations
4. I understand that violations may result in disciplinary action or legal consequences
5. I will use lab resources exclusively for authorized security research purposes

**Analyst Signature:** ______________________

**Date:** __________

---

**For questions or clarifications, contact:** security@example.com
